Skip to content
Thursday, February 12, 2026
Latest:
  • Partners in crime – genes ATP13A2 and GBA1 interact to drive neurodegeneration
  • How healthy is your crawfish boil?
  • When childhood heart conditions become adult heart disease
  • From lab bench to bedside – research in mice leads to answers for undiagnosed human neurodevelopmental conditions
  • Thyroid 101
Baylor College of Medicine Blog Network

  • Home
  • Momentum
    • About Momentum
    • Resources
    • Contributors
      • Taylor Barnes
      • Dana Benson
      • Molly Chiu
      • Julie Garcia
      • Graciela Gutierrez
      • Anna Kiappes
      • Andy Phifer
      • Homa Shalchi
      • Melissa Tucker
    • Contact Us
  • From The Labs
    • About From the Labs
    • Follow From The Labs on Twitter
  • Policywise
    • About PolicyWise
    • Follow @BCMEthics on Twitter
  • The Stitch
    • About The Stitch
  • Progress Notes
    • About Progress Notes
    • Progress Notes Editors
    • Connect With Us
  • bcm.edu

Mpro

From The Labs

Innovative, faster and more cost-effective technology identifies drug that inhibits SARS-CoV-2 growth in the lab

August 31, 2021 COVID-19,  COVID-19 drugs,  DNA-Encoded Chemistry Technology.,  drug discovery,  Mpro,  Research,  SARS-CoV-2

Baylor College of Medicine researchers are contributing to the development of antiviral drugs to treat people with COVID-19.

Read More

From the Labs: Image of the Month

Close up of neurons from the brain cortex of a mouse with Huntington's disease. From the Labs: Human intestinal organoid

Healthy Habits: A DOC-umentary Series

https://www.youtube.com/watch?v=SlNiMWHUhbc

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951